national stem-cell therapy logo

NurOwn: Revolutionizing ALS Treatment with Biomarkers

BrainStorm Logo

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapeutics for neurodegenerative diseases, has presented new biomarker data from the Phase 3 trial of its late-stage investigational ALS treatment, NurOwn, at the 2023 ALS and Related Motor Neuron Diseases Gordon Research Conference. The data showed that treatment with NurOwn significantly elevated markers of […]

Unlocking the Brain’s Secret Weapon: The Power of Neural Stem Cells!

illustration of a healthy and colorful human brain

The Therapeutic Potential of Neural Stem Cells Imagine a construction site. The workers there are like cells in our body, each with a specific job to do. But among them, there are a few who are like the site managers, capable of taking on any role as needed. These are the stem cells, the body’s […]

Stem Cells in Space: The Unexpected Solution to Age-Related Diseases?

illustration of a scientist in outer space

Age-related diseases like stroke, cancer, dementia, and other neurodegenerative conditions present significant challenges to patients and families, and pose an escalating health burden in the United States. Stem cell-based therapies may provide a solution, but creating large numbers of stem cells is challenging. To address this, scientists in regenerative medicine are using the International Space […]

BrainStorm Cell Therapeutics Announces Type A Meeting with FDA Granted for NurOwn®

BrainStorm Logo

NEW YORK, Dec. 27, 2022 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted a Type A meeting to discuss the contents of a refusal to file letter previously issued regarding the company’s New Biologics License Application […]

BrainStorm to Announce Second Quarter Results and Provide a Corporate Update

BrainStorm Logo

NEW YORK, Aug. 1, 2022 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today that it will hold a conference call to update shareholders on financial results for the second quarter, ended on June 30, 2022, and provide a corporate update, at 8:00 a.m. Eastern […]

Stem cells helping patients with Parkinson’s Disease

First FDA approved stem cell trial for Parkinson's Disease

News segment from Houston’s KPRC talking about the first FDA approved stem cell trial that is happening to help patient’s dealing with Parkinson’s Disease. Video Transcript: More than 10 million people worldwide are living with Parkinson’s and 60,000 are in the U.S.. It’s a chronic progressive disease, which means it gets worse over time. But […]

The Impact of T Cells in Neurodegenerative Disease and Regenerative Therapies

The Impact of T Cells in Neurodegenerative Disease and Regenerative Therapies

UCI Sue and Bill Gross Stem Cell Research Center Lecture by Craig Walsh, Ph.D. talking a little bit about the immune system and how particular types of cells of the immune system called T cells; the roles that they play in neurodegenerative diseases, and talk about multiple sclerosis and Alzheimer’s disease. And in particular how […]

Facts About Parkinson’s Disease You Need to Know

Parkinson's Disease

Did you know that Parkinson’s disease is the second most common neurodegenerative disease in the world? Or that it affects more than 1 million people in the United States alone? If you didn’t, don’t worry – you’re not alone. In this blog post, we will discuss 10 facts about Parkinson’s disease that everyone should know. […]